These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12529759)

  • 1. Soluble tissue actor interferes with angiostatin-mediated inhibition of endothelial cell proliferation by lysine-specific interaction with plasminogen kringle domains.
    Albrecht S; Magdolen V; Herzog U; Miles L; Kirschenhofer A; Baretton G; Luther T
    Thromb Haemost; 2002 Dec; 88(6):1054-9. PubMed ID: 12529759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis.
    Ji WR; Barrientos LG; Llinás M; Gray H; Villarreal X; DeFord ME; Castellino FJ; Kramer RA; Trail PA
    Biochem Biophys Res Commun; 1998 Jun; 247(2):414-9. PubMed ID: 9642142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells.
    Cao Y; Ji RW; Davidson D; Schaller J; Marti D; Söhndel S; McCance SG; O'Reilly MS; Llinás M; Folkman J
    J Biol Chem; 1996 Nov; 271(46):29461-7. PubMed ID: 8910613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of the NG2 proteoglycan to kringle domains modulates the functional properties of angiostatin and plasmin(ogen).
    Goretzki L; Lombardo CR; Stallcup WB
    J Biol Chem; 2000 Sep; 275(37):28625-33. PubMed ID: 10889192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3.
    MacDonald NJ; Murad AC; Fogler WE; Lu Y; Sim BK
    Biochem Biophys Res Commun; 1999 Oct; 264(2):469-77. PubMed ID: 10529387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis.
    Ji WR; Castellino FJ; Chang Y; Deford ME; Gray H; Villarreal X; Kondri ME; Marti DN; Llinás M; Schaller J; Kramer RA; Trail PA
    FASEB J; 1998 Dec; 12(15):1731-8. PubMed ID: 9837863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site.
    Ahn JH; Lee HJ; Lee EK; Yu HK; Lee TH; Yoon Y; Kim SJ; Kim JS
    Biol Chem; 2011 Apr; 392(4):347-56. PubMed ID: 21194375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth.
    Cao Y; Chen A; An SS; Ji RW; Davidson D; Llinás M
    J Biol Chem; 1997 Sep; 272(36):22924-8. PubMed ID: 9278456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiostatin selectively inhibits signaling by hepatocyte growth factor in endothelial and smooth muscle cells.
    Wajih N; Sane DC
    Blood; 2003 Mar; 101(5):1857-63. PubMed ID: 12406896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiostatin binds to tyrosine kinase substrate annexin II through the lysine-binding domain in endothelial cells.
    Tuszynski GP; Sharma MR; Rothman VL; Sharma MC
    Microvasc Res; 2002 Nov; 64(3):448-62. PubMed ID: 12453439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils.
    Scapini P; Nesi L; Morini M; Tanghetti E; Belleri M; Noonan D; Presta M; Albini A; Cassatella MA
    J Immunol; 2002 Jun; 168(11):5798-804. PubMed ID: 12023382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
    Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
    Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of endothelial cell proliferation by the recombinant kringle domain of tissue-type plasminogen activator.
    Kim HK; Lee SY; Oh HK; Kang BH; Ku HJ; Lee Y; Shin JY; Hong YK; Joe YA
    Biochem Biophys Res Commun; 2003 May; 304(4):740-6. PubMed ID: 12727218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer.
    Sim BK; O'Reilly MS; Liang H; Fortier AH; He W; Madsen JW; Lapcevich R; Nacy CA
    Cancer Res; 1997 Apr; 57(7):1329-34. PubMed ID: 9102221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of interkringle disulfide bond of plasminogen kringle 1-3 changes the lysine binding capability of kringle 2, but not its antiangiogenic activity.
    Lee H; Kim HK; Lee JH; You WK; Chung SI; Chang SI; Park MH; Hong YK; Joe YA
    Arch Biochem Biophys; 2000 Mar; 375(2):359-63. PubMed ID: 10700393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis.
    Cao R; Wu HL; Veitonmäki N; Linden P; Farnebo J; Shi GY; Cao Y
    Proc Natl Acad Sci U S A; 1999 May; 96(10):5728-33. PubMed ID: 10318952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells.
    Tarui T; Miles LA; Takada Y
    J Biol Chem; 2001 Oct; 276(43):39562-8. PubMed ID: 11514539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation.
    Stack MS; Gately S; Bafetti LM; Enghild JJ; Soff GA
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):77-84. PubMed ID: 10229661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage formation of angiostatin during inflammation. A byproduct of the activation of plasminogen.
    Falcone DJ; Khan KM; Layne T; Fernandes L
    J Biol Chem; 1998 Nov; 273(47):31480-5. PubMed ID: 9813061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR.
    Marti DN; Hu CK; An SS; von Haller P; Schaller J; Llinás M
    Biochemistry; 1997 Sep; 36(39):11591-604. PubMed ID: 9305949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.